Genomenon and BeginNGS: The Promising Future of Newborn Sequencing

The new BeginNGS™ program, based at the Rady Children’s Institute for Genomic Medicine (RCIGM), is a novel health care delivery system designed to screen newborns for genetic diseases and connect their doctors with effective treatment options. It will improve infant patient outcomes by providing clinicians with powerful insight on how these diseases form, and how to treat them, creating life-saving opportunities for patients and their families at very early stages.

Mastermind: The premier resource of BeginNGS

As part of our mission to curate the entire human genome, Genomenon will combine AI-powered organization and expert manual review to fully curate all the genes in the BeginNGS screening panel – genes tied to over 400 diseases – and provide RCIGM with a comprehensive, actionable dataset on the variants that are found to cause disease. Read more here.

‍

‍